FINANCIAL STATEMENT ANALYSIS

USED BY US DEPARTMEN OF EDUCATION, UNIVERSITIES, STUDENTS & ACCOUNTING PRO'S

VentureLine tracks and provides 5-year financial statement analysis on approximately 7,000+ publicly traded companies; the SEC-traceable data is updated weekly. For your convenience you can access that current company financial statement analysis information by clicking directly on the Company Name, visit their Website or enter the Company name or Ticker symbol, e.g. enter 'Microsoft' or 'MSFT' for Microsoft, in the Company Search window below.

FINANCIAL STATEMENT ANALYSIS UPDATED: JULY 24, 2022

Results 251 through 277 of 277

- SIC # 2830

Ticker Exchange Company Financial Reports SIC #
TGTX Nasdaq TG Therapeutics, Inc. 2830
TIL Nasdaq Instil Bio, Inc. 2830
TNGX Nasdaq Tango Therapeutics, Inc. 2830
TNYA Nasdaq Tenaya Therapeutics, Inc. 2830
TSHA Nasdaq Taysha Gene Therapies, Inc. 2830
TVGN Nasdaq Tevogen Bio Holdings Inc. 2830
TXMD Nasdaq TherapeuticsMD, Inc. 2830
UG Nasdaq United-Guardian, Inc. 2830
UPC Nasdaq Universe Pharmaceuticals INC 2830
UPXI Nasdaq Upexi, Inc. 2830
URGN Nasdaq UroGen Pharma Ltd. 2830
VALN Nasdaq Valneva SE 2830
VCEL Nasdaq Vericel Corporation 2830
VERA Nasdaq Vera Therapeutics, Inc. 2830
VIR Nasdaq Vir Biotechnology, Inc. 2830
VOR Nasdaq Vor Biopharma Inc. 2830
VRDN Nasdaq Viridian Therapeutics, Inc. 2830
VRNO Over the counter Verano Holdings Corp. 2830
VRTX Nasdaq Vertex Pharmaceuticals Incorporated 2830
VTGN Nasdaq Vistagen Therapeutics, Inc. 2830
VYNE Nasdaq VYNE Therapeutics Inc. 2830
XBIT Nasdaq XBiotech Inc. 2830
XFOR Nasdaq X4 Pharmaceuticals, Inc. 2830
ZEOX Over the counter Zeo ScientifiX, Inc. 2830
ZLAB Nasdaq Zai Lab Limited 2830
ZURA Nasdaq Zura Bio Limited 2830
ZYBT Nasdaq Zhengye Biotechnology Holding Limited 2830
Results 250 through 277 of 277